Voyager Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYGR and other ETFs, options, and stocks.About VYGR
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01.
CEOAlfred W. Sandrock
CEOAlfred W. Sandrock
Employees172
Employees172
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded2013
Founded2013
Employees172
Employees172
VYGR Key Statistics
Market cap218.23M
Market cap218.23M
Price-Earnings ratio-1.81
Price-Earnings ratio-1.81
Dividend yield—
Dividend yield—
Average volume403.30K
Average volume403.30K
High today$3.97
High today$3.97
Low today$3.85
Low today$3.85
Open price$3.94
Open price$3.94
Volume452.95K
Volume452.95K
52 Week high$6.27
52 Week high$6.27
52 Week low$2.65
52 Week low$2.65
Stock Snapshot
With a market cap of 218.23M, Voyager Therapeutics(VYGR) trades at $3.94. The stock has a price-to-earnings ratio of -1.81.
As of 2025-12-31, Voyager Therapeutics(VYGR) stock has fluctuated between $3.85 and $3.97. The current price stands at $3.94, placing the stock +2.3% above today's low and -0.8% off the high.
The Voyager Therapeutics(VYGR)'s current trading volume is 452.95K, compared to an average daily volume of 403.3K.
In the last year, Voyager Therapeutics(VYGR) shares hit a 52-week high of $6.27 and a 52-week low of $2.65.
In the last year, Voyager Therapeutics(VYGR) shares hit a 52-week high of $6.27 and a 52-week low of $2.65.
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own VYGR. This list is generated using Robinhood data, and it’s not a recommendation.